Selected research
Industry Research
PLA Vascular Scaffold Industry Research Report 2026
Market perspective
The global PLA Vascular Scaffold market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for PLA Vascular Scaffold is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for PLA Vascular Scaffold is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for PLA Vascular Scaffold is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of PLA Vascular Scaffold include MicroPort Scientific, Shanghai Bio-heart Biological Technology Co., Ltd., Shandong Huaan Biotechnology Co., Ltd., Lepu Medical, Beijing Advanced Medical Technologies Co., Ltd., KyotoMedical, Elixir Medical and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global PLA Vascular Scaffold market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PLA Vascular Scaffold Market by Company
MicroPort Scientific
Shanghai Bio-heart Biological Technology Co., Ltd.
Shandong Huaan Biotechnology Co., Ltd.
Lepu Medical
Beijing Advanced Medical Technologies Co., Ltd.
KyotoMedical
Elixir Medical
Abbott Laboratories
PLA Vascular Scaffold Segment by Type
Supportive Type
Therapeutic Type
PLA Vascular Scaffold Segment by Application
Hospitals
Outpatient Surgery Center
Others
PLA Vascular Scaffold Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PLA Vascular Scaffold market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PLA Vascular Scaffold and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PLA Vascular Scaffold.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of PLA Vascular Scaffold manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of PLA Vascular Scaffold by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of PLA Vascular Scaffold in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Supportive Type
- Therapeutic Type
Applications
- Hospitals
- Outpatient Surgery Center
- Others
Companies covered
- MicroPort Scientific
- Shanghai Bio-heart Biological Technology Co., Ltd.
- Shandong Huaan Biotechnology Co., Ltd.
- Lepu Medical
- Beijing Advanced Medical Technologies Co., Ltd.
- KyotoMedical
- Elixir Medical
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global PLA Vascular Scaffold Market Size (2021-2032)
- 2.2.2 Global PLA Vascular Scaffold Sales (2021-2032)
- 2.2.3 Global PLA Vascular Scaffold Market Average Price (2021-2032)
- 2.3 PLA Vascular Scaffold by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Supportive Type
- 2.3.3 Therapeutic Type
- 2.4 PLA Vascular Scaffold by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Outpatient Surgery Center
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global PLA Vascular Scaffold Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global PLA Vascular Scaffold Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global PLA Vascular Scaffold Revenue of Manufacturers (2021-2026)
- 3.4 Global PLA Vascular Scaffold Average Price by Manufacturers (2021-2026)
- 3.5 Global PLA Vascular Scaffold Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of PLA Vascular Scaffold, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of PLA Vascular Scaffold, Product Type & Application
- 3.8 Global Manufacturers of PLA Vascular Scaffold, Established Date
- 3.9 Global PLA Vascular Scaffold Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 MicroPort Scientific
- 4.1.1 MicroPort Scientific Company Information
- 4.1.2 MicroPort Scientific Business Overview
- 4.1.3 MicroPort Scientific PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 MicroPort Scientific PLA Vascular Scaffold Product Portfolio
- 4.1.5 MicroPort Scientific Recent Developments
- 4.2 Shanghai Bio-heart Biological Technology Co., Ltd.
- 4.2.1 Shanghai Bio-heart Biological Technology Co., Ltd. Company Information
- 4.2.2 Shanghai Bio-heart Biological Technology Co., Ltd. Business Overview
- 4.2.3 Shanghai Bio-heart Biological Technology Co., Ltd. PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Bio-heart Biological Technology Co., Ltd. PLA Vascular Scaffold Product Portfolio
- 4.2.5 Shanghai Bio-heart Biological Technology Co., Ltd. Recent Developments
- 4.3 Shandong Huaan Biotechnology Co., Ltd.
- 4.3.1 Shandong Huaan Biotechnology Co., Ltd. Company Information
- 4.3.2 Shandong Huaan Biotechnology Co., Ltd. Business Overview
- 4.3.3 Shandong Huaan Biotechnology Co., Ltd. PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Huaan Biotechnology Co., Ltd. PLA Vascular Scaffold Product Portfolio
- 4.3.5 Shandong Huaan Biotechnology Co., Ltd. Recent Developments
- 4.4 Lepu Medical
- 4.4.1 Lepu Medical Company Information
- 4.4.2 Lepu Medical Business Overview
- 4.4.3 Lepu Medical PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lepu Medical PLA Vascular Scaffold Product Portfolio
- 4.4.5 Lepu Medical Recent Developments
- 4.5 Beijing Advanced Medical Technologies Co., Ltd.
- 4.5.1 Beijing Advanced Medical Technologies Co., Ltd. Company Information
- 4.5.2 Beijing Advanced Medical Technologies Co., Ltd. Business Overview
- 4.5.3 Beijing Advanced Medical Technologies Co., Ltd. PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Beijing Advanced Medical Technologies Co., Ltd. PLA Vascular Scaffold Product Portfolio
- 4.5.5 Beijing Advanced Medical Technologies Co., Ltd. Recent Developments
- 4.6 KyotoMedical
- 4.6.1 KyotoMedical Company Information
- 4.6.2 KyotoMedical Business Overview
- 4.6.3 KyotoMedical PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 KyotoMedical PLA Vascular Scaffold Product Portfolio
- 4.6.5 KyotoMedical Recent Developments
- 4.7 Elixir Medical
- 4.7.1 Elixir Medical Company Information
- 4.7.2 Elixir Medical Business Overview
- 4.7.3 Elixir Medical PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Elixir Medical PLA Vascular Scaffold Product Portfolio
- 4.7.5 Elixir Medical Recent Developments
- 4.8 Abbott Laboratories
- 4.8.1 Abbott Laboratories Company Information
- 4.8.2 Abbott Laboratories Business Overview
- 4.8.3 Abbott Laboratories PLA Vascular Scaffold Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Abbott Laboratories PLA Vascular Scaffold Product Portfolio
- 4.8.5 Abbott Laboratories Recent Developments
5 Global PLA Vascular Scaffold Market Scenario by Region
- 5.1 Global PLA Vascular Scaffold Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global PLA Vascular Scaffold Sales by Region: 2021-2032
- 5.2.1 Global PLA Vascular Scaffold Sales by Region: 2021-2026
- 5.2.2 Global PLA Vascular Scaffold Sales by Region: 2027-2032
- 5.3 Global PLA Vascular Scaffold Revenue by Region: 2021-2032
- 5.3.1 Global PLA Vascular Scaffold Revenue by Region: 2021-2026
- 5.3.2 Global PLA Vascular Scaffold Revenue by Region: 2027-2032
- 5.4 North America PLA Vascular Scaffold Market Facts & Figures by Country
- 5.4.1 North America PLA Vascular Scaffold Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America PLA Vascular Scaffold Sales by Country (2021-2032)
- 5.4.3 North America PLA Vascular Scaffold Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe PLA Vascular Scaffold Market Facts & Figures by Country
- 5.5.1 Europe PLA Vascular Scaffold Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe PLA Vascular Scaffold Sales by Country (2021-2032)
- 5.5.3 Europe PLA Vascular Scaffold Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific PLA Vascular Scaffold Market Facts & Figures by Country
- 5.6.1 Asia Pacific PLA Vascular Scaffold Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific PLA Vascular Scaffold Sales by Country (2021-2032)
- 5.6.3 Asia Pacific PLA Vascular Scaffold Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America PLA Vascular Scaffold Market Facts & Figures by Country
- 5.7.1 South America PLA Vascular Scaffold Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America PLA Vascular Scaffold Sales by Country (2021-2032)
- 5.7.3 South America PLA Vascular Scaffold Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa PLA Vascular Scaffold Market Facts & Figures by Country
- 5.8.1 Middle East and Africa PLA Vascular Scaffold Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa PLA Vascular Scaffold Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa PLA Vascular Scaffold Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global PLA Vascular Scaffold Sales by Type (2021-2032)
- 6.1.1 Global PLA Vascular Scaffold Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global PLA Vascular Scaffold Sales Market Share by Type (2021-2032)
- 6.2 Global PLA Vascular Scaffold Revenue by Type (2021-2032)
- 6.2.1 Global PLA Vascular Scaffold Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global PLA Vascular Scaffold Revenue Market Share by Type (2021-2032)
- 6.3 Global PLA Vascular Scaffold Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global PLA Vascular Scaffold Sales by Application (2021-2032)
- 7.1.1 Global PLA Vascular Scaffold Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global PLA Vascular Scaffold Sales Market Share by Application (2021-2032)
- 7.2 Global PLA Vascular Scaffold Revenue by Application (2021-2032)
- 7.2.1 Global PLA Vascular Scaffold Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global PLA Vascular Scaffold Revenue Market Share by Application (2021-2032)
- 7.3 Global PLA Vascular Scaffold Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 PLA Vascular Scaffold Value Chain Analysis
- 8.1.1 PLA Vascular Scaffold Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 PLA Vascular Scaffold Production Mode & Process
- 8.2 PLA Vascular Scaffold Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 PLA Vascular Scaffold Distributors
- 8.2.3 PLA Vascular Scaffold Customers
9 Global PLA Vascular Scaffold Analyzing Market Dynamics
- 9.1 PLA Vascular Scaffold Industry Trends
- 9.2 PLA Vascular Scaffold Industry Drivers
- 9.3 PLA Vascular Scaffold Industry Opportunities and Challenges
- 9.4 PLA Vascular Scaffold Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst